Characterization of the antitumor-promoting activity of camptothecin in SENCAR mouse skin

Carcinogenesis

Volumn 17, Issue 5, 1996, Pages 1141-1148

  Gao, Xiao Mei ^a   Perchellet, Elisabeth M ^a   Davis, Amy W ^a   Newell, Steven W ^a   Hua, Duy H ^b   Perchellet, Jean Pierre ^a  

^a Anti Cancer Drug Laboratory   (United States)

^b KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; CAMPTOTHECIN; DNA; DNA TOPOISOMERASE; ORNITHINE DECARBOXYLASE; PHORBOL 13 ACETATE 12 MYRISTATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CARCINOGEN DNA INTERACTION; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CARCINOGENESIS; TUMOR PROMOTION;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; DITERPENES; DNA REPLICATION; DNA TOPOISOMERASES, TYPE I; FEMALE; MICE; SKIN NEOPLASMS; TERPENES; TETRADECANOYLPHORBOL ACETATE;

EID: 0029888552     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.5.1141     Document Type: Article

References (39)

1. Slaga,T.J. (1984) Multistage skin tumor promotion and specificity of inhibition. In Slaga,T.J. (ed.), Mechanisms of Tumor Promotion. CRC Press, Boca Raton, FL, Vol. 2, pp. 189-196.
2. Perchellet,J.P. and Perchellet,E.M. (1989) Antioxidants and multistage carcinogenesis in mouse skin. Free Radical Biol. Med., 7, 377-408.
3. DiGiovanni,J. (1992) Multistage carcinogenesis in mouse skin. Pharmacol. Ther., 54, 63-128.
4. Wall,M.E. and Wani,M.C. (1995) Camptothecin and taxol: discovery to clinic - 13th Bruce F.Cain Memorial Award Lecture. Cancer Res., 55, 753-760.
5. Potmesil,M. (1994) Camptothecins: from bench research to hospital wards. Cancer Res., 54, 1431-1439.
6. Hashimoto,H., Chatterjee,S. and Berger,N.A. (1995) Mutagenic activity of topoisomerase I inhibitors. Proc. Am. Ass. Cancer Res., 36, 442.
7. Perchellet,J.P., Gao,X.M., Perchellet,E.M., Newell,S.W., Chen,G. and Hua,D.H. (1995) Ability of camptothecin to inhibit the biochemical events linked to the tumor-promoting component of carcinogenesis in mouse epidermis in vivo. Int. J. Oncol., 7 (suppl.), 1005.
8. Gao,X.M., Perchellet,E.M., Newell,S.W., Chen,G., Hua,D.H. and Perchellet,J.P. (1995) Ability of camptothecin to inhibit the biochemical markers of mouse skin tumor promotion in vivo. Proc. Am. Ass. Cancer Res., 36, 441.
9. Gao,X.M., Perchellet,E.M., Chen,G., Newell,S.W. and Perchellet,J.P. (1994) Characterization of the tumor-promoting activity of thapsigargin in CF-1 mouse skin. Int. J. Oncol., 5, 793-803.
10. Boutwell,R.K. (1976) The biochemistry of preneoplasia in mouse skin. Cancer Res., 36, 2631-2635.
11. Slaga,T.J., Bowden,G.T., Shapas,B.G. and Boutwell,R.K. (1974) Macromolecular synthesis following a single application of polycyclic hydrocarbons used as initiators of mouse skin carcinogenesis. Cancer Res., 34, 771-777.
12. Baird,W.M., Sedgwick,J.A. and Boutwell,R.K. (1971) Effects of phorbol and four diesters of phorbol on the incorporation of tritiated precursors into DNA, RNA, and protein in mouse epidermis. Cancer Res., 31, 1434-1439.
13. Battarola,M.St.J., Kruszewski,F.H. and DiGiovanni,J. (1993) Inhibition of chrysarobin skin tumor promotion in SENCAR mice by antioxidants. Carcinogenesis, 14, 2507-2512.
14. Hennings,H., Bowden,G.T. and Boutwell,R.K. (1969) The effect of croton oil pretreament on skin tumor initiation in mice. Cancer Res., 29, 1773-1780.
15. Bowden,G.T. and Boutwell,R.K. (1974) Studies on the role of stimulated epidermal DNA synthesis in the initiation of skin tumors in mice by N-methyl-N′-nitro-N-nitrosoguanidine. Cancer Res., 34, 1552-1563.
16. Hennings,H., Michael,D. and Patterson,E. (1978) Croton oil enhancement of skin tumor initiation by N-methyl-N′-nitro-N-nitrosoguanidine: possible role of DNA replication. Proc. Soc. Exp. Biol. Med., 158, 1-4.
17. Hennings,H. and Yuspa,S.H. (1985) Two-stage tumor promotion in mouse skin: an alternative explanation. J. Natl Cancer Inst., 74, 735-740.
18. Ewing,M.W., Conti,C.J., Phillips,J.L., Slaga,T.J. and DiGiovanni,J. (1989) Further characterization of skin tumor promotion and progression by mezerein in SENCAR mice. J. Natl Cancer Inst., 81, 676-682.
19. Hsiang,Y.-H., Hertzberg,R., Hecht,S. and Liu,L.F. (1985) Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J. Biol. Chem., 260, 14873-14878.
20. Madden,K.R. and Champoux,J.J. (1992) Overexpression of human topoisomerase I in baby hamster kidney cells: hypersensitivity of clonal isolates to camptothecin. Cancer Res., 52, 525-532.
21. Holm,C., Covey,J.M., Kerrigan,D. and Pommier,Y. (1989) Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells. Cancer Res., 49, 6365-6368.
22. Tsao,Y.-P., Russo,A., Nyamuswa,G., Silber,R. and Liu,L.F. (1993) Interaction between replication forks and topoisomerase I-DNA cleavable complexes: studies in a cell-free SV40 DNA replication system. Cancer Res., 53, 5908-5914.
23. Ryan,A.J., Squires,S., Strutt,H.L., Evans,A. and Johnson,R.T. (1994) Different fates of camptothecin-induced replication fork-associated double-strand DNA breaks in mammalian cells. Carcinogenesis, 15, 823- 828.
24. Pantazis,P., Kozielski,A.J., Vardeman,D.M., Petry,E.R. and Giovanella,B.C. (1993) Efficacy of camptothecin congeners in the treatment of human breast carcinoma xenografts. Oncology Res., 5, 273-281.
25. Husain,I., Mohler,J.L., Seigler,H.F. and Besterman,J.M. (1994) Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumors: demonstration of tumor-type specificity and implication for cancer chemotherapy. Cancer Res., 54, 539-546.
26. Hsiang,Y.-H., Liu,L.F., Wall,M.E., Wani,M.C., Nicholas,A.W., Manikumar,G., Kirschenbaum,S., Silber,R. and Potmesil,M. (1989) DNA topoisomerase I-mediated cleavage and cytotoxicity of camptothecin analogues. Cancer Res., 49, 4385-4389.
27. DiGiovanni,J., Fisher,E.P. and Sawyer,T.W. (1986) Kinetics of formation and disappearance of 7,12-dimethylbenz[a]anthracene:DNA adducts in mouse epidermis. Cancer Res., 46, 4400-4405.
28. Cerutti,P.A. (1988) Response modification creates promotability in multistage carcinogenesis. Carcinogenesis, 9, 519-526.
29. Halmekytö,M., Syrjänen,K., Jänne,J. and Alhonen,L. (1992) Enhanced papilloma formation in response to skin tumor promotion in transgenic mice overexpressing the human ornithine decarboxylase gene. Biochem. Biophys. Res. Commun., 187, 493-497.
30. Auvinen,M., Paasinen,A., Andersson,L.C. and Hölttä,E. (1992) Ornithine decarboxylase activity is critical for cell transformation. Nature, 360, 355-358.
31. Clifford,A., Morgan,D., Yaspa,S.H., Soler,A.P. and Gilmour,S. (1995) Role of ornithine decarboxylase in epidermal tumorigenesis. Cancer Res., 55, 1680-1686.
32. Kinzel,V., Loehrke,H., Goerttler,K., Furstenberger,G. and Marks,F. (1984) Suppression of the first stage of phorbol 12-tetradecanoate 13-acetate-effected tumor promotion in mouse skin by nontoxic inhibition of DNA synthesis. Proc. Natl Acad. Sci. USA, 81, 5858-5862.
33. Hsiang,Y.-H., Lihou,M.G. and Liu,L.F. (1989) Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. Cancer Res., 49, 5077-5082.
34. Ryan,A.J., Squires,S., Strutt,H.L. and Johnson,R.T. (1991) Camptothecin cytotoxicity in mammalian cells is associated with the induction of persistent double-strand breaks in replicating DNA. Nucleic Acids Res., 19, 3295-3300.
35. Squires,S., Ryan,A.J., Strutt,H.L. and Johnson,R.T. (1993) Hypersensitivity of Cockayne's syndrome cells to camptothecin is associated with the generation of abnormally high levels of double strand breaks in nascent DNA. Cancer Res., 53, 2012-2019.
36. cdc2/cyclin B. Cancer Res., 52, 1823-1829.
37. Hwong,C.-L., Chen,M.-S. and Hwang,J. (1989) Phorbol ester transiently increases topoisomerase I mRNA levels in human skin fibroblasts. J. Biol. Chem., 264, 14923-14926.
38. Gardellini,E. and Durban,E. (1993) Phosphorylation of human topoisomerase I by protein kinase C in vitro and in phorbol 12-myristate 13-acetate-activated HL-60 promyelocytic leukaemia cells. Biochem. J., 291, 303-307.
39. Samuels,D.S., Shimizu,Y., Nakabayashi,T. and Shimizu,N. (1994) Phosphorylation of DNA topoisomerase I is increased during the response of mammalian cells to mitogenic stimuli. Biochim. Biophys. Acta, 1223, 77-83.